140 related articles for article (PubMed ID: 19594)
1. Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats.
Braestrup C
J Pharm Pharmacol; 1977 Aug; 29(8):463-70. PubMed ID: 19594
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
Braestrup C; Scheel-Krüger J
Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.
Ross SB; Kelder D
Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143
[TBL] [Abstract][Full Text] [Related]
4. Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine.
Fuller RW; Snoddy HD
J Pharm Pharmacol; 1979 Mar; 31(3):183-4. PubMed ID: 34697
[No Abstract] [Full Text] [Related]
5. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
6. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
7. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Worms P; Kan JP; Wermuth CG; Roncucci R; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
[TBL] [Abstract][Full Text] [Related]
8. Clorgyline-induced increases in presynaptic DA: changes in the behavioral and neurochemical effects of amphetamine using in vivo microdialysis.
Segal DS; Kuczenski R; Okuda C
Pharmacol Biochem Behav; 1992 Jul; 42(3):421-9. PubMed ID: 1409775
[TBL] [Abstract][Full Text] [Related]
9. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
Mignot E; Laude D
J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397
[TBL] [Abstract][Full Text] [Related]
10. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
Fessler RG; Sturgeon RD; Meltzer HY
Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
12. Basal and amphetamine-induced asymmetries in striatal dopamine release and metabolism: bilateral in vivo microdialysis in normal rats.
Glick SD; Carlson JN; Baird JL; Maisonneuve IM; Bullock AE
Brain Res; 1988 Nov; 473(1):161-4. PubMed ID: 3208119
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis.
Butcher SP; Liptrot J; Aburthnott GW
Neurosci Lett; 1991 Jan; 122(2):245-8. PubMed ID: 1902922
[TBL] [Abstract][Full Text] [Related]
14. A comparison of circling models for the detection of antiparkinson activity.
Costall B; Naylor RJ
Psychopharmacologia; 1975; 41(1):57-64. PubMed ID: 1091939
[TBL] [Abstract][Full Text] [Related]
15. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
16. Antagonism by methylphenidate of the stereotyped behaviour produced by (+)-amphetamine in reserpinized rats.
Ross SB
J Pharm Pharmacol; 1978 Apr; 30(4):253-4. PubMed ID: 24718
[No Abstract] [Full Text] [Related]
17. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
18. Involvement of brain monoamines in the stimulant and paradoxical inhibitory effects of methylphenidate.
Breese GR; Cooper BR; Hollister AS
Psychopharmacologia; 1975 Oct; 44(1):5-10. PubMed ID: 128026
[TBL] [Abstract][Full Text] [Related]
19. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
[TBL] [Abstract][Full Text] [Related]
20. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
